Relugolix

CAS 737789-87-6

In Stock

Relugolix

Cat. No. STUB-API-RELUGOLIXCAS 737789-87-6In Stock

Technical Data

Cat. No.STUB-API-RELUGOLIX

CAS737789-87-6

Mol. FormulaC₂₉H₂₇F₂N₇O₅S

Mol. Weight623.642 g/mol

IUPAC1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea

SMILESCN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC

InChIInChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)

InChI KeyAOMXMOCNKJTRQP-UHFFFAOYSA-N

Purity—

Description

Overview

Relugolix is used in men to treat advanced prostate cancer. Relugolix is a type of medicine called a gonadotropin-releasing hormone (GnRH) antagonist

Anant Labs manufacture and furnish high quality Relugolix impurities for global markets. Our Relugolix EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

Relugolix737789-87-6TAK-385OrgovyxTAK 385TAK385P76B05O5V6DTXSID40224167MYFEMBREE COMPONENT RELUGOLIXN-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea

Browse APIs A–Z